000			02018 a2200613 4500
005			20250514180443.0
264		0	_c20040323
008			200403s 0 0 eng d
022			_a0017-5749
024	7		_a10.1136/gut.2003.020107 _2doi
040			_aNLM _beng _cNLM
100	1		_aStallmach, A
245	0	0	_aAn interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo. _h[electronic resource]
260			_bGut _cMar 2004
300			_a339-45 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aColitis _xchemically induced
650	0	4	_aCrohn Disease _ximmunology
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xmetabolism
650	0	4	_aInterferon-gamma _xbiosynthesis
650	0	4	_aInterleukin-12 _xmetabolism
650	0	4	_aInterleukin-12 Subunit p40
650	0	4	_aLeukocytes, Mononuclear _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aProtein Subunits _xmetabolism
650	0	4	_aReceptors, Interleukin _xmetabolism
650	0	4	_aReceptors, Interleukin-12
650	0	4	_aRecombinant Fusion Proteins _xmetabolism
650	0	4	_aTrinitrobenzenesulfonic Acid
700	1		_aMarth, T
700	1		_aWeiss, B
700	1		_aWittig, B M
700	1		_aHombach, A
700	1		_aSchmidt, C
700	1		_aNeurath, M
700	1		_aZeitz, M
700	1		_aZeuzem, S
700	1		_aAbken, H
773	0		_tGut _gvol. 53 _gno. 3 _gp. 339-45
856	4	0	_uhttps://doi.org/10.1136/gut.2003.020107 _zAvailable from publisher's website
999			_c14683645 _d14683645